Showing results (71-80 of 86) with videos related to
Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|December 10, 2015
Phase I study assessing the feasibility of the triple combination chemotherapy of SOXIRI (S-1/oxaliplatin/irinotecan) in patients with unresectable pancreatic ductal adenocarcinomaHiroaki Yanagimoto, Sohei Satoi, Masayuki Sho, et al.JOP : Journal of the Pancreas|November 13, 2013
Laparoscopic distal pancreatectomy for a pancreatic lymphoepithelial cyst: case report and review of literatureHiroaki Yanagimoto, Sohei Satoi, Hideyoshi Toyokawa, et al.Trials|February 6, 2022
Randomized phase III trial of intravenous and intraperitoneal paclitaxel with S-1 versus gemcitabine plus nab-paclitaxel for pancreatic ductal adenocarcinoma with peritoneal metastasis (SP study)Tomohisa Yamamoto, Tsutomu Fujii, Satoshi Hirano, et al.Gastro Hep Advances|October 27, 2025
Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic CancerAyaka Takaori, Tsukasa Ikeura, Daisuke Hashimoto, et al.Journal of Hepato-Biliary-Pancreatic Sciences|December 2, 2021
Synopsis of a clinical practice guideline for pancreatic ductal adenocarcinoma with peritoneal dissemination in Japan; Japan Peritoneal Malignancy Study GroupSohei Satoi, Naminatsu Takahara, Tsutomu Fujii, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 23, 2023
Impact of neoadjuvant therapy on gut microbiome in patients with resectable/borderline resectable pancreatic ductal adenocarcinomaAyaka Takaori, Daisuke Hashimoto, Tsukasa Ikeura, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 13, 2024
Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or borderline resectable pancreatic ductal adenocarcinomaMotonobu Maruo, Tsukasa Ikeura, Ayaka Takaori, et al.Journal of Gastrointestinal Oncology|May 10, 2021
Conversion surgery in patients with pancreatic cancer and peritoneal metastasisSuguru Yamada, Tsutomu Fujii, Tomohisa Yamamoto, et al.Annals of Surgical Oncology|September 1, 2025
Favorable Response Defined by CA19-9 Reduction After Neoadjuvant Treatment for Pancreatic CancerYuya Ashitomi, Fuyuhiko Motoi, Atsushi Oba, et al.Surgery Today|February 15, 2023
The academic impact and value of an international online surgery lecture seriesDaisuke Hashimoto, Aiste Gulla, Sohei Satoi, et al.Pageof 9